Company performance
Add to research
Current Price
as of May 20, 2025$16.29
P/E Ratio
N/A
Market Cap
$2.25B
Description
Add to research
Arrowhead Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development of medicines that treat intractable diseases by silencing the genes that cause them. The firms preclinical stage drug candidates include ARO-ANG3, ARO-AAT, ARO-APOC3, ARO-HIF2, ARO-HSD, ARO-Lung2, ARO-COV, and ARO-ENaC. The company was founded by Robert Bruce Stewart in 1989 and is headquartered in Pasadena, CA.
Metrics
Add to research
Overview
- HQPasadena, CA
- SectorHealth Technology
- IndustryBiotechnology
- TickerARWR
- Price$16.29+3.49%
Trading Information
- Market cap$2.25B
- Float83.42%
- Average Daily Volume (1m)1,694,784
- Average Daily Volume (3m)1,844,583
- EPS-$1.36
Company
- Revenue$545.21M
- Rev growth (1yr)N/A
- Net income$370.45M
- Gross margin98.88%
- EBITDA margin71.36%
- EBITDA$387.29M
- EV$1.36B
- EV/Revenue2.49
- P/EN/A
- P/S4.02
- P/B3.29
- Debt/Equity108.37
Documents
Add to research
SEC Filings
Factset Street Account
Earnings Calls
Factset